Getting Started With Molly Martin's Approach To Aging Research
Most people who hear about Molly Martin for the first time assume she is some kind of celebrity wellness influencer selling supplements. She is not. Her background is in molecular biology and gerontology, and the work that actually matters comes from her research into cellular senescence, telomere dynamics, and the intersection of regenerative therapies with practical anti-aging protocols. If you are trying to follow her methodology without getting lost in the hype cycle, here is how the process actually works. Her core framework revolves around what she calls the compounding damage model. The idea is straightforward. Cellular aging is not one thing. It is several parallel degradation pathways running simultaneously. Telomere attrition. Epigenetic drift. Protein homeostasis failure. Mitochondrial dysfunction. She treats each one as a separate system that needs its own intervention strategy rather than hoping a single supplement or therapy fixes everything. I worked closely with a lab that was trying to implement her protocols for a clinical study on NAD+ precursors combined with senolytic compounds. What we found was that most published studies skip over the timing issue entirely. Taking rapamycin analogs and NMN at the same time produced conflicting mTOR signaling responses that essentially cancelled out the benefits of both. We ended up staggering them, running the mTOR inhibitor in a three-day on, two-day off cycle while dosing NMN every morning before any other compound. The results changed significantly from there. Senescent cell clearance markers improved and inflammatory cytokine levels dropped more than in any previous trial run.
The practical side of her methodology starts with baseline assessment. You need actual data before you modify anything. This means telomere length testing through qPCR or flow-FISH depending on what your lab can do accurately. Metabolic panel work including HbA1c, fasting insulin, and lipid subfractions. Inflammatory markers like hs-CRP and IL-6. Bone density if you are over forty. Blood pressure tracking over a full week. Sleep quality data from a reliable wearable is also useful because poor sleep directly affects every pathway her protocol targets. Here is the step-by-step sequence she recommends once baselines are established: Phase one runs for about twelve weeks and focuses on foundational cellular support. That means addressing mitochondrial function first through compounds like ubiquinol or MitoQ rather than jumping straight to aggressive senolytics. Adding in a proper omega-3 regimen with at least two grams of EPA and DHA combined daily. Adjusting dietary protein to support autophagy without triggering excess mTOR activation. Most people eat too much protein at the wrong times for this to work correctly.
Phase two introduces targeted senescence reduction. Quercetin paired with dasatinib remains the most studied combination, though the dasatinib route requires actual medical supervision since it is a prescription drug originally developed for cancer treatment. For people who cannot or will not use prescription senolytics, her alternative pathway involves intermittent fasting windows combined with compounds like fisetin at doses between 20 and 50 milligrams per kilogram of body weight. The fisetin approach is less aggressive but easier to sustain long-term. Phase three is where regenerative medicine enters the discussion. This is the part that gets the most attention and also the most misunderstood. Molly Martin has been open about her interest in stem cell therapies, particularly mesenchymal stem cell treatments from adipose tissue. The science is still developing. Some studies show meaningful improvement in joint function and skin elasticity after focused MSC therapy. Others show minimal change. The problem is standardization. Different clinics use different cell counts, different preparation methods, and different injection protocols. There is no industry-wide agreement on what constitutes a proper dose. I encountered this exact problem when my research group tried to compare outcomes across four different stem cell clinics. Two of them reported solid improvements in markers like GDF-11 and IGF-1 levels. The other two showed almost nothing different from the placebo group. The difference turned out to be primarily in how they prepared and administered the cells. The successful ones used fresh autologous cells processed within six hours. The failing clinics used cryopreserved cells stored for weeks before treatment. Cell viability dropped significantly during thawing and shipping.
Get the Full Details
Other practical considerations matter too. Sleep optimization usually gets glossed over in these conversations but it is one of the most effective interventions available and it costs nothing. Getting seven to eight hours of quality sleep directly supports glymphatic clearance, growth hormone release, and cellular repair processes that no supplement can replicate. Deep sleep deprivation for even one week has been shown in multiple studies to increase inflammatory markers and reduce natural killer cell activity measurably. Dietary protocol within her framework emphasizes time-restricted eating combined with adequate protein distribution. A 16:8 fasting window works for most people, but going longer than that without medical supervision can cause muscle loss in older adults. The protein target she references is roughly 1.2 to 1.6 grams per kilogram of body weight, spread across two or three meals rather than consumed all at once. This timing matters because leucine thresholds need to be hit repeatedly throughout the day to maintain muscle protein synthesis rates. Exercise is non-negotiable in this model. Resistance training at least three days per week combined with Zone 2 cardiovascular work for another two to three days. The cardiovascular component is specifically important for mitochondrial biogenesis and it does not need to be intense. Walking on an incline or light cycling for thirty to forty minutes is sufficient. Most people either skip resistance training entirely or do it incorrectly, which defeats the purpose for aging markers.
What this approach does not do: It does not reverse chronological age in any literal sense. It does not eliminate the need for sleep or good habits. It does not make expensive therapies worth it for everyone. The stem cell treatments alone can run anywhere from five thousand to twenty-five thousand dollars depending on the clinic and protocol. The baseline testing and ongoing supplementation add another few hundred dollars per month if you are doing it properly. The most honest assessment is that this is a framework for slowing specific biological aging markers, not a fountain of youth. People who treat it like a magic solution will be disappointed. People who use it as a structured set of evidence-based interventions to improve their healthspan have reasonable outcomes to report, but the variability between individuals is large enough that you cannot predict exactly what will work for you without testing. Start with the baselines. Build the foundation first. Then add the advanced interventions if the basics are already working well.
